An Analytical Reference Standard
Features
  • This product has been formulated as an exempt preparation which meets criteria established by the US DEA
  • Possession of a DEA Controlled Substance registration is not necessary nor is a DEA 222 form required to purchase this product
  • This product is intended to be used as an analytical reference standard
  • Bulk material is available for academic research at qualified institutions; please contact our sales department for pricing
Related Products
Alternative(s)
16192Heroin-d3
Labeled Version(s)
9001543Heroin ISO60187Heroin (CRM)9003076Heroin (hydrochloride)
Non-Exempt Preparation(s)
40095Heroin-d9
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Heroin-d9 (exempt preparation)

Item No. 42070

Exempt Product (US)
Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Synonyms
Synonyms
  • Acetomorphine-d9
  • 3,6-Diacetylmorphine-d9
  • Diamorphine-d9
Technical Information
Formal Name
l7,8-didehydro-4,5-epoxy-17-methyl-d3-(5α,6α)-3,6-diacetate-d6-morphinan-3,6-diol
CAS Number
1338713-49-7
Molecular Formula
C21H14D9NO5
Formula Weight
378.5
Purity
≥99% deuterated forms (d1-d9)
Formulation
A 100 µg/ml solution in acetonitrile
SMILES
[H][C@]12[C@]3(CCN(C([2H])([2H])[2H])[C@@H]2C4)[C@](OC5=C3C4=CC=C5OC(C([2H])([2H])[2H])=O)([H])[C@H](C=C1)OC(C([2H])([2H])[2H])=O
InChi Code
InChI=1S/C21H23NO5/c1-11(23)25-16-6-4-13-10-15-14-5-7-17(26-12(2)24)20-21(14,8-9-22(15)3)18(13)19(16)27-20/h4-7,14-15,17,20H,8-10H2,1-3H3/t14-,15+,17-,20-,21-/m0/s1/i1D3,2D3,3D3
InChi Key
GVGLGOZIDCSQPN-OYCCCKEBSA-N
Regulatory Information
DEA Exempt Notification
This product is a DEA exempt preparation of a scheduled compound - does not require DEA Controlled Substance registration or DEA 222 form. For alternate sizes please contact sales.
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    100 µg

    $54

    Add
    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    Heroin-d9 (exempt preparation) (Item No. 42070) is intended for use as an internal standard for the quantification of heroin (Item Nos. ISO60187 | 9001543 | 9003076) by GC- or LC-MS. Heroin is categorized as an opioid.1,2 Heroin-d9 is regulated as a Schedule I compound in the United States. Heroin-d9 (exempt preparation) (Item No. 42070) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zuccaro, P., Ricciarello, R., Pichini, S., et al. Simultaneous determination of heroin 6-monoacetylmorphine, morphine, and its glucuronides by liquid chromatography-atmospheric pressure ionspray-mass spectrometry. J. Anal. Toxicol. 21(4), 268-277 (1997).

    2. Cone, E.J., Jufer, R., Darwin, W.D., et al. Forensic drug testing for opiates. VII. Urinary excretion profile of intranasal (snorted) heroin. J. Anal. Toxicol. 20(6), 379-392 (1996).

    Product Citations

    Kerrigan, J.E., Oleksyszyn, J., Kam, C.-M., et al. Mechanism-based isocoumarin inhibitors for human leukocyte elastase. Effect of the 7-amino substituent and 3-alkoxy group in 3-alkoxy-7-amino-4-chloroisocoumarins on inhibitory potency. J. Med. Chem. 38(3), 544-552 (1995).